Global Antimicrobial Susceptibility TestingMarket
The global antimicrobial susceptibility testingmarket is estimated to be worth over USD6.4 Bnin 2033 and is expected to grow at CAGR of 5.5% during the forecast period (2024-2033). The global antimicrobial susceptibility testing (AST) market is experiencingrobustprogressfueled by major factors, notable developments, and the integration of cutting-edge technologies. A chief driving force is the growing concern over antimicrobial resistance, fostering a greater demand for accurate and swift AST solutions. The overuse and misuse of antibiotics across the world have paved its way to the emergence of multi-drug resistant pathogens, highlighting the crucial need for effective diagnostic tools. Significant developments involve a change towards advanced testing methodologies, such as molecular techniques like PCR and genotypic testing, providingquicker and more accurate identification of resistance mechanisms. In addition to that, there is a pronounced trend towards the adoption of automated systems in the AST market, enhancingefficacy and streamlining the testing process.
A notable market opportunity lies in the penetration into untapped regions where evaluation to advanced diagnostic technologies is limited. This strategic expansion tackles unmet needs, contributes to effective antimicrobial stewardship, and streamlines with the global imperative to enhance infectious disease management. However, the market witnesses’ restraints, comprising limited accessibility in resource-constrained settings and hindrances in standardizing testing methodologies and result interpretation, which is likely to impact the reliability of data.
Latest technologies in the AST market comprise the integration of artificial intelligence (AI) and machine learning (ML) algorithms. These technologies improve result interpretation, assisting in the identification of resistance patterns and offering more nuanced insights. The confluence of AI and ML contributes to the evolution of AST, making it a more sophisticated and efficient tool for guiding clinical decision-making. Overall, the global antimicrobial susceptibility testing market stands ready for sustained growth as stakeholders prioritize innovation to combat antimicrobial resistance and enhance the accuracy of infectious disease diagnostics on a global scale.
The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different geographies. Amongst other elements, the market report includes:
A preface providing an introduction to the full report, Antimicrobial Susceptibility Testingmarket, 2023-2033.
An outline of the systematic research methodology adopted to conduct the study on Antimicrobial Susceptibility Testingmarket, providing insights on the various assumptions, methodologies, and quality control measures employed to ensure accuracy and reliability of our findings.
An overview of economic factors that impact the overall Antimicrobial Susceptibility Testingmarket, including historical trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
An executive summary of the insights captured during our research, offering a high-level view of the current state of the Antimicrobial Susceptibility Testingmarket and its likely evolution in the mid-to-long term.
A brief introduction to the Antimicrobial Susceptibility Testing, highlighting their historical background, as well as information on their types, key aspects, key challenges and the advantages of using Antimicrobial Susceptibility Testing.
A detailed assessment of the market landscape of Antimicrobial Susceptibility Testingthat are either approved or being evaluated in different stages of development, based on several relevant parameters, such as By Product (Manual Antimicrobial Susceptibility Testing Products (Susceptibility Discs, Susceptibility Plates, Minimum Inhibitory Concentration (MIC) Strips), Consumables, Automated Antimicrobial Susceptibility Testing Products), By Method (Disc Diffusion, Automated AST, Dilution, Other Methods(Other methods include Etest, genotypic methods, and MALDI-TOF MS.)), By Application (Clinical Diagnostics, Drug Discovery and Development, Other Applications(Other applications include epidemiology, veterinary diagnostic, and environmental monitoring)), By End User (Diagnostic Laboratories and Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Institutes). Further, the chapter features analysis on key niche market segments. In addition, the chapter features analysis of various Antimicrobial Susceptibility Testingdevelopers, based on their year of establishment, company size, location of headquarters and most active players.
An in-depth analysis of partnerships and collaborations that have been inked between various stakeholders, since 2019, based on several relevant parameters, such as the year of partnership, type of partnership, focus of partnership, purpose of partnership, therapeutic applications and most active players (in terms of number of partnerships). It also highlights the regional distribution of partnership activity in this market.
A detailed analysis of various investments made by companies engaged in this industry, since 2019, based on several relevant parameters, such as year of funding, type of funding (grants, seed, venture capital, initial public offering, secondary offerings, private equity and debt financing), type of HPAPIs, amount invested, geography, purpose of funding, stage of development, therapeutic area, most active players (in terms of number and amount of funding instances) and leading investors (in terms of number of funding instances).
An in-depth analysis of the various Antimicrobial Susceptibility Testingfocused initiatives undertaken by big market players, based on several relevant parameters, such as number of initiatives, year of initiative, type of initiative, purpose of initiative, focus of initiative and location of headquarters of the big pharma players.
One of the key objectives of this market report was to estimate the current market size and the future growth potential of the Antimicrobial Susceptibility Testingover the forecast period. Based on several parameters, such as regional analysis as well as segmental analysis rates, we have developed informed estimates of the likely evolution of the Antimicrobial Susceptibility Testingmarket over the forecast period 2023-2033. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as By Product (Manual Antimicrobial Susceptibility Testing Products (Susceptibility Discs, Susceptibility Plates, Minimum Inhibitory Concentration (MIC) Strips), Consumables, Automated Antimicrobial Susceptibility Testing Products), By Method (Disc Diffusion, Automated AST, Dilution, Other Methods(Other methods include Etest, genotypic methods, and MALDI-TOF MS.)), By Application (Clinical Diagnostics, Drug Discovery and Development, Other Applications(Other applications include epidemiology, veterinary diagnostic, and environmental monitoring)), By End User (Diagnostic Laboratories and Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Institutes), by key geographical regions (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) and leading players. In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s evolution.